Eko Health vs SimpleSense

Eko's low ejection fraction tool was cleared on March 28, 2024 (K233409). Nanowear's cuffless blood pressure software, SimpleSense-BP, was cleared on December 8, 2023 (K232053). Both are 510(k) decisions, and neither vendor shows a health-system price.

Nanowear fits a heart failure program that wants a cloth garment worn at home to feed cloud analytics, plus continuous blood pressure without a cuff. The 303-subject validation of that blood pressure monitor was written by Nanowear-affiliated authors and is an internal validation, and the authors ask for external validation. Eko fits a cardiology or primary care group that wants a stethoscope with murmur analysis and an ECG-based low ejection fraction check at the visit.

For a heart failure clinic that must justify a vendor to its health system, funding matters. Tracxn lists $1.52 million raised over two rounds for Nanowear, and ZoomInfo says under $5 million. Wikipedia lists a $41 million Series D for Eko in 2024, which leaves Nanowear the thinner-funded vendor.